Allogeneic hematopoietic cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy27

Allografts T-Lymphocytes Hematopoietic Stem Cells CD8-Positive T-Lymphocytes Antilymphocyte Serum Bone Marrow Cells Fetal Blood Hematopoietic System CD4-Positive T-Lymphocytes Bone Marrow Cells, Cultured Killer Cells, Natural Blood Cells T-Lymphocytes, Regulatory Spleen Stem Cells Lymphocytes Cell Line Thymus Gland B-Lymphocytes Liver Mesenchymal Stromal Cells Dendritic Cells T-Lymphocytes, Cytotoxic Granulocytes Clone Cells Transplants

Organisms16

Transplantation Chimera Mice, Inbred C57BL Mice, Inbred BALB C Cytomegalovirus Swine, Miniature Radiation Chimera Chimera Dogs Mice, SCID Retroviridae Mice, Knockout Rats, Inbred Lew Mice, Inbred NOD Mice, Inbred Strains Mice, Transgenic Mice, Inbred C3H

Diseases43

Graft vs Host Disease Hematologic Neoplasms Leukemia, Myeloid, Acute Recurrence Leukemia Myelodysplastic Syndromes Hematologic Diseases Precursor Cell Lymphoblastic Leukemia-Lymphoma Acute Disease Leukemia, Myelogenous, Chronic, BCR-ABL Positive Lymphoma, Non-Hodgkin Lymphoproliferative Disorders Chronic Disease Lymphoma Cytomegalovirus Infections Multiple Myeloma Anemia, Aplastic Mycoses Hepatic Veno-Occlusive Disease Mucopolysaccharidosis I Roseolovirus Infections Severe Combined Immunodeficiency Leukemia, Myeloid Hodgkin Disease Infection Neoplasm, Residual Gonadal Disorders Postoperative Complications Fanconi Anemia Neoplasms, Second Primary Liver Diseases Leukemia, Lymphocytic, Chronic, B-Cell Neoplasm Recurrence, Local Disease Models, Animal Neoplasms Liver Failure Disease Progression Kidney Diseases Blood Group Incompatibility Opportunistic Infections Primary Myelofibrosis Bronchiolitis Obliterans Cadaver

Chemicals and Drugs39

Myeloablative Agonists Vidarabine Busulfan HLA Antigens Minor Histocompatibility Antigens Immunosuppressive Agents Cyclosporine Mycophenolic Acid Tacrolimus Cyclophosphamide Antineoplastic Agents Antilymphocyte Serum Antigens, CD34 Receptors, KIR Melphalan Astatine Complementarity Determining Regions Antibodies, Monoclonal Antigens, CD Isoantigens Granulocyte Colony-Stimulating Factor Antigens, CD45 Pyrimidines Benzamides Cytarabine Interleukin-3 Carmustine Etoposide Fusion Proteins, bcr-abl Hematopoietic Cell Growth Factors Ganciclovir Isoantibodies Thiotepa Antineoplastic Agents, Alkylating Recombinant Proteins Cytokines Vincristine Histocompatibility Antigens ABO Blood-Group System

Analytical, Diagnostic and Therapeutic Techniques and Equipment87

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Transplantation Conditioning Whole-Body Irradiation Transplantation, Autologous Histocompatibility Testing Treatment Outcome Peripheral Blood Stem Cell Transplantation Bone Marrow Transplantation Retrospective Studies Cord Blood Stem Cell Transplantation Donor Selection Stem Cell Transplantation Survival Analysis Remission Induction Survival Rate Disease-Free Survival Liver Transplantation Follow-Up Studies Combined Modality Therapy Immunosuppression Risk Factors Kidney Transplantation Salvage Therapy Lymphocyte Depletion Cell Transplantation Prognosis Cohort Studies Transplantation Heart Transplantation Incidence Lung Transplantation Prospective Studies Antineoplastic Combined Chemotherapy Protocols Transplantation, Isogeneic Lymphocyte Transfusion Islets of Langerhans Transplantation Organ Transplantation Hematopoietic Stem Cell Mobilization Mesenchymal Stem Cell Transplantation Multivariate Analysis Pancreas Transplantation Lymphatic Irradiation Flow Cytometry Skin Transplantation Transplantation, Heterotopic Immunotherapy, Adoptive Radioimmunotherapy Kaplan-Meier Estimate Transplantation, Heterologous Fetal Tissue Transplantation Lymphocyte Culture Test, Mixed Cytogenetic Analysis Disease Models, Animal Polymerase Chain Reaction Heart-Lung Transplantation Clinical Trials as Topic Colony-Forming Units Assay Karnofsky Performance Status Cell Separation Leukocyte Transfusion Proportional Hazards Models Corneal Transplantation Adoptive Transfer Immunophenotyping Lymphocyte Activation Risk Leukapheresis Tissue Transplantation Fatal Outcome Cause of Death Severity of Illness Index Transduction, Genetic Bone Marrow Purging Brain Tissue Transplantation Risk Assessment Case-Control Studies Cell Culture Techniques Lymphocyte Count Feasibility Studies Actuarial Analysis Models, Animal Blood Transfusion, Autologous Neoplasm Transplantation Cell Count Leukocyte Count Coculture Techniques

Psychiatry and Psychology2

Siblings Nuclear Family

Phenomena and Processes33

Graft vs Tumor Effect Graft vs Leukemia Effect Chimerism Histocompatibility Graft Survival Graft Rejection Time Factors Transplantation Immunology Hematopoiesis Virus Activation Transplantation Tolerance Cell Differentiation Complementarity Determining Regions Immune Tolerance Major Histocompatibility Complex Radiation Chimera Cell Lineage Graft vs Host Reaction Immunocompromised Host Lymphocyte Activation Risk Cell Division Transduction, Genetic Genetic Vectors Cytotoxicity, Immunologic Cell Survival Cell Proliferation Genotype Haplotypes Lymphocyte Count Host vs Graft Reaction Cell Count Leukocyte Count

Anthropology, Education, Sociology and Social Phenomena4

Siblings National Cancer Institute (U.S.)Quality of Life Nuclear Family

Humanities1

Quality of Life

Information Science4

Survival Rate Incidence Fatal Outcome Cause of Death

Named Groups6

Unrelated Donors Tissue Donors Siblings Living Donors Survivors Infant, Newborn

Health Care31

Treatment Outcome Retrospective Studies Donor Selection Survival Analysis Survival Rate Disease-Free Survival Follow-Up Studies Risk Factors Age Factors Cohort Studies Incidence Directed Tissue Donation Prospective Studies National Cancer Institute (U.S.)Multivariate Analysis Blood Banks Kaplan-Meier Estimate Clinical Trials as Topic Tissue and Organ Procurement Karnofsky Performance Status Proportional Hazards Models Risk Fatal Outcome Comorbidity Cause of Death Severity of Illness Index Waiting Lists Risk Assessment Case-Control Studies Feasibility Studies Actuarial Analysis

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Transplantation Conditioning Graft vs Host Disease Hematologic Neoplasms Myeloablative Agonists Unrelated Donors Whole-Body Irradiation Graft vs Tumor Effect Tissue Donors Graft vs Leukemia Effect Transplantation, Autologous Vidarabine Histocompatibility Testing Treatment Outcome Transplantation Chimera Peripheral Blood Stem Cell Transplantation Leukemia, Myeloid, Acute Bone Marrow Transplantation Chimerism Recurrence Retrospective Studies Cord Blood Stem Cell Transplantation Histocompatibility Siblings Busulfan Donor Selection Leukemia Stem Cell Transplantation Graft Survival Survival Analysis HLA Antigens Minor Histocompatibility Antigens Myelodysplastic Syndromes Remission Induction Immunosuppressive Agents Survival Rate Disease-Free Survival Hematologic Diseases Allografts Precursor Cell Lymphoblastic Leukemia-Lymphoma Acute Disease Graft Rejection Cyclosporine Liver Transplantation T-Lymphocytes Follow-Up Studies Mycophenolic Acid Leukemia, Myelogenous, Chronic, BCR-ABL Positive Time Factors Combined Modality Therapy Immunosuppression Lymphoma, Non-Hodgkin Hematopoietic Stem Cells Risk Factors Living Donors Tacrolimus Lymphoproliferative Disorders Cyclophosphamide Chronic Disease Kidney Transplantation Salvage Therapy Lymphocyte Depletion Lymphoma Cell Transplantation Transplantation Immunology Age Factors Prognosis Cohort Studies Antineoplastic Agents Transplantation Cytomegalovirus Infections CD8-Positive T-Lymphocytes Heart Transplantation Incidence Hematopoiesis Multiple Myeloma Directed Tissue Donation Survivors Lung Transplantation Antilymphocyte Serum Prospective Studies Anemia, Aplastic Mycoses Mice, Inbred C57BL Hepatic Veno-Occlusive Disease Bone Marrow Cells Antineoplastic Combined Chemotherapy Protocols Transplantation, Isogeneic Lymphocyte Transfusion Islets of Langerhans Transplantation Mucopolysaccharidosis I Organ Transplantation Antigens, CD34 Hematopoietic Stem Cell Mobilization Mice, Inbred BALB C Virus Activation National Cancer Institute (U.S.)Roseolovirus Infections Receptors, KIR

No FAQ available that match "allogeneic hematopoietic cell transplantation"